Warburg Research set a €89.00 ($103.49) target price on Symrise (FRA:SY1) in a report released on Wednesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other research firms have also recently weighed in on SY1. Morgan Stanley set a $70.00 price objective on shares of Edison International and gave the company a hold rating in a research report on Monday, July 15th. Independent Research set a €215.00 ($250.00) price objective on shares of Munchener Ruckvers and gave the company a neutral rating in a research report on Wednesday, May 8th. UBS Group raised their price objective on shares of LyondellBasell Industries from $86.00 to $89.00 and gave the company a neutral rating in a research report on Thursday, July 11th. Barclays restated a hold rating and set a $52.00 price objective on shares of Biohaven Pharmaceutical in a research report on Tuesday, March 19th. Finally, Baader Bank set a €53.00 ($61.63) price objective on shares of Compugroup Medical and gave the company a neutral rating in a research report on Tuesday, April 30th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the stock. Symrise currently has an average rating of Hold and an average price target of €79.50 ($92.44).

Symrise stock opened at €82.36 ($95.77) on Wednesday. The firm’s fifty day moving average is €85.46. Symrise has a fifty-two week low of €56.96 ($66.23) and a fifty-two week high of €73.48 ($85.44).

About Symrise

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Read More: How is diluted EPS different from basic EPS?

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.